Efficacy and Safety of DLBS1425 in Subjects With Advanced/Metastatic Breast Cancer
Status:
Terminated
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are :
- to investigate the safety and clinical efficacy of sole therapy with DLBS1425 in
suppressing disease-(tumour) progression in subjects with advanced/metastatic breast
cancer; and
- to determine the minimal effective and safe dose of DLBS1425 in the therapy of
advanced/metastatic breast cancer